The effect of peptide YY, a gastrointestinal hormone, on the expression of the apolipoprotein A-IV gene in the intestinal epithelial cell line Caco-2 was examined by semiquantitative RT-PCR followed by Southern hybridization with an inner oligonucleotide probe. Apolipoprotein A-IV mRNA levels were increased in response to peptide YY in a dose- and time-dependent fashion. Western blotting revealed that the exogenous peptide YY increased the intracellular concentration of apolipoprotein A-IV. In contrast, apolipoprotein A-I, B, and C-III mRNA did not respond to peptide YY. Differentiated Caco-2 cells expressed Y1– but not Y2- and Y5-receptor subtype mRNA. The present results suggest that peptide YY modulates apolipoprotein A-IV gene expression, likely via the Y1-receptor subtype in intestinal epithelial cells.
Get full access to this article
View all access options for this article.
References
1.
ElshourbagyNA, BoguskiMS, LiaoWSL, JeffersonLS, GordonJI, TaylorJM. Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin. Proc Natl Acad Sci U S A82:8242–3246, 1985.
2.
ChenCH, AlbersJJ. Activation of lecithin: Cholesterol acyltransferase by apolipoproteins E-2, E-3, and A-IV isolated from human plasma. Biochim Biophys Acta836:279–285, 1985.
3.
DvorinE, GorderNL, BensonDM, GottoAMJr. Apolipoprotein A-IV: A determinant for binding and uptake of high density lipoproteins by rat hepatocytes. J Biol Chem261:15714–15728, 1986.
4.
SteinO, SteinY, LefevreM, RoheimPS. The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biochim Biophys Acta878:7–13, 1986.
5.
SteinmetzA, UtermannG.Activation of lecithin: Cholesterol acyltransferase by human apolipoprotein A-IV. J Biol Chem260:2258–2264, 1985.
6.
SteinmetzA, BarbarasR, GhalimN, ClaveyV, FruchartJC, AilhaudG.Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem265:7859–7863, 1990.
7.
FujimotoK, CardelliJA, TsoP.Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation. Am J Physiol262:G1002–G1006, 1992.
8.
FujimotoK, FukagawaK, SakataT, TsoP.Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J Clin Invest91:1830–1833, 1993.
9.
OkumuraT, FukagawaK, TsoP, TaylorIL, PappasTN. Intracisternal injection of apolipoprotein A-IV inhibits gastric secretion in pylorus-ligated conscious rats. Gastroenterology107:1861–1864, 1994.
10.
OkumuraT, FukagawaK, TsoP, TaylorIL, PappasTN, UeharaA, KohgoY.Delayed gastric emptying by central apolipoprotein A-IV in rats. Gastroenterology108:A996, 1995.
11.
SonoyamaK, KiriyamaS, NikiR.Adaptive response of apolipoprotein A-I and A-IV mRNA in residual ileum after massive small bowel resection in rats. J Nutr Sci Vitaminol41:253–264, 1995.
12.
SonoyamaK, NakamuraY, KiriyamaS, NikiR.Upregulation of apolipoprotein A-IV gene expression in residual ileum after massive small bowel resection requires the biliary secretion in rats. Proc Soc Exp Biol Med211:273–280, 1996.
13.
SonoyamaK, AoyamaY.Different responses of apolipoprotein A-I. A-IV. and B gene expression during intestinal adaptation to a massive small bowel resection in rats. Biosci Biotechnol Biochem61:1810–1813, 1997.
14.
Ali-RachediA, VarndellIM, AdrianTE, GappDA, Van NoordenS, BloomSR, PolakJM. Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas. Histochemistry80:487–491, 1984.
15.
BoucherG, SjolundK, EkbladE, HakansonR, SchwartzTW, SundlerF.Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut. Regul Pept8:261–266, 1984.
16.
SavageAP, GornaczGE, AdrianTE, GhateiMA, GoodladRA, WrightNA, BloomSR. Is raised plasma peptide YY after intestinal resection in the rat responsible for the trophic response?Gut26:1353–1358, 1985.
17.
TaylorRG, BeveridgeDJ, FullerPJ. Expression of ileal glucagon and peptide tyrosine-tyrosine genes: Response to inhibition of polyamine synthesis in the presence of massive small-bowel resection. Biochem J286:737–741, 1992.
18.
FullerPJ, BeveridgeDJ, TaylorRG. Ileal proglucagon gene expression in the rat: Characterization in intestinal adaptation using in situ hybridization. Gastroenterology104:459–466, 1993.
19.
GordonJI. Intestinal epithelial differentiation: New insights from chimeric and transgenic mice. J Cell Biol108:1187–1194, 1989.
20.
LevyE, MehranM, SeidmanE.Caco-2 cells as a model for intestinal lipoprotein synthesis and secretion. FASEB J9:626–635, 1995.
21.
DavidsonNO, MagunAM, BrasitusTA, GlickmanRM. Intestinal apolipoprotein A-I and B-48 metabolism: Effects of sustained alterations in dietary triglyceride and mucosal cholesterol flux. J Lipid Res28:388–402, 1987.
22.
FidgeNH. The redistribution and metabolism of iodinated apolipoprotein A-IV in rats. Biochim Biophys Acta619:129–141, 1980.
23.
HayashiH, FujimotoK, CardelliJA, NuttingDF, BergstedtS, TsoP.Fat feeding increases size, but not number, of chylomicrons produced by small intestine. Am J Physiol259:G709–G719, 1990.
24.
WeinbergRB, DantzkerC, PattonCS. Sensitivity of serum apolipoprotein A-IV levels to changes in dietary fat content. Gastroenterology98:17–24, 1990.
25.
KarathanasisSK. Apolipoprotein multigene family: Tandem organization of human apolipoprotein AI, CIII, and AIV genes. Proc Natl Acad Sci U S A82:6374–6378, 1985.
26.
PappasTN, DebasHT, GotoY, TaylorIL. Peptide YY inhibits meal-stimulated pancreatic and gastric secretion. Am J Physiol248:G118–G123, 1985.
27.
AponteGW, FinkAS, MeyerJH, TatemotoK, TaylorIL. Regional distribution and release of peptide YY with fatty acids of different chain length. Am J Physiol249:G745–G750, 1985.
28.
AponteGW, ParkK, HessR, GarciaR, TaylorIL. Meal-induced peptide tyrosine tyrosine inhibition of pancreatic secretion in the rat. FASEB J3:1949–1955, 1989.
29.
GordonJI, SmithDP, AlpersDH, StraussAW. Cloning of a complementary deoxyribonucleic acid encoding a portion of rat intestinal preapolipoprotein AIV messenger ribonucleic acid. Biochemistry21:5424–5431, 1982.
30.
HalldénG, AponteGW. Evidence for a role of the gut hormone PYY in the regulation of intestinal fatty acid-binding protein transcripts in differentiated subpopulations of intestinal epithelial cell hybrids. J Biol Chem272:12591–12600, 1997.
31.
GordonJI, ElshourbagyN, LoweJB, LiaoWS, AlpersDH, TaylorJM. Tissue-specific expression and developmental regulation of two genes coding for rat fatty acid binding proteins. J Biol Chem260:1995–1998, 1985.
32.
HsuKT, StorchJ.Fatty acid transfer from liver and intestinal fatty acid binding proteins to membranes occurs by different mechanisms. J Biol Chem271:13317–13323, 1996.
33.
BassNM. The cellular fatty acid binding proteins: Aspects of structure, regulation, and function. Int Rev Cytol111:143–184, 1988.
34.
RubinDC, SwietlickiEA, WangJL, DodsonBD, LevinMS. Enterocytic gene expression in intestinal adaptation: Evidence for a specific cellular response. Am J Physiol270:G143–G152, 1996.
35.
BlomqvistAG, HerzogH.Y-receptor subtypes: How many more?Trends Neurosci20:294–298, 1997.
36.
KalogerisTJ, QinX, CheyWY, TsoP.PYY stimulates synthesis and secretion of intestinal apolipoprotein A-IV without affecting mRNA expression. Am J Physiol275:G668–G674, 1998.
37.
ChenCH, RogersRC. Central inhibitory action of peptide YY on gastric motility in rats. Am J Physiol269:R787–R792, 1995.
